OBJECTIVE To observe the clinical efficacy of ginkgo leaf tablets on ischemic

stroke with syndrome of blood stasis. METHODS In therapy group ginkgo leaf

tablets were given orally by 1 pill three times a day. In control group Naoxintong

capsules were given orally by 4 capsules three times a day. The course of

treatment was 8 weeks. Clinical efficacy, traditional Chinese medicine symptom

efficacy and hemorheology changes were evaluated. RESULTS The total effective

rates of clinical efficacy in therapy group and control group were 86.67% and

82.61%, and the traditional Chinese medicine symptom efficacy were 88.89%

and 82.61%. In both groups, there were statistically significant differences

between pre- and post-treatment on neurological deficit scale score and hemorheology changes.

But there was no significant difference between two groups.

CONCLUSION The ginkgo leaf tablets show predominant efficacy on ischemic

stroke with syndrome of blood stasis.